 | • レポートコード：QYR9ST05845 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、アベルマブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、注入に、用途別には、メルケル細胞癌、非小細胞肺癌（NSCLC）、その他にセグメント区分し、アベルマブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・アベルマブの世界市場概要 ・アベルマブの製造コスト構成分析 ・アベルマブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・アベルマブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・アベルマブのセグメント分析（種類別） （注入） ・アベルマブのセグメント分析（用途別） （メルケル細胞癌、非小細胞肺癌（NSCLC）、その他） ・アベルマブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Merck、Pfizer） ・アベルマブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Avelumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Avelumab volume and value at global level, regional level and company level. From a global perspective, this report represents overall Avelumab market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Avelumab in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Avelumab manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
Pfizer
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
By Usage
Injection
By Specifications
200mg/Per
Segment by Application
Merkel-cell Carcinoma
Non-small Cell Lung Carcinoma (NSCLC)
Other
Table of Contents
Executive Summary
1 Industry Overview of Avelumab
1.1 Definition of Avelumab
1.2 Avelumab Segment By Usage
1.2.1 Global Avelumab Production Growth Rate Comparison By Usage (2014-2025)
1.2.2 Injection
1.2.3
1.3 Avelumab Segment by Applications
1.3.1 Global Avelumab Consumption Comparison by Applications (2014-2025)
1.3.2 Merkel-cell Carcinoma
1.3.3 Non-small Cell Lung Carcinoma (NSCLC)
1.3.4 Other
1.4 Global Avelumab Overall Market
1.4.1 Global Avelumab Revenue (2014-2025)
1.4.2 Global Avelumab Production (2014-2025)
1.4.3 North America Avelumab Status and Prospect (2014-2025)
1.4.4 Europe Avelumab Status and Prospect (2014-2025)
1.4.5 China Avelumab Status and Prospect (2014-2025)
1.4.6 Japan Avelumab Status and Prospect (2014-2025)
1.4.7 Southeast Asia Avelumab Status and Prospect (2014-2025)
1.4.8 India Avelumab Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Avelumab
2.3 Manufacturing Process Analysis of Avelumab
2.4 Industry Chain Structure of Avelumab
3 Development and Manufacturing Plants Analysis of Avelumab
3.1 Capacity and Commercial Production Date
3.2 Global Avelumab Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Avelumab
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Avelumab Production and Capacity Analysis
4.2 Avelumab Revenue Analysis
4.3 Avelumab Price Analysis
4.4 Market Concentration Degree
5 Avelumab Regional Market Analysis
5.1 Avelumab Production by Regions
5.1.1 Global Avelumab Production by Regions
5.1.2 Global Avelumab Revenue by Regions
5.2 Avelumab Consumption by Regions
5.3 North America Avelumab Market Analysis
5.3.1 North America Avelumab Production
5.3.2 North America Avelumab Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Avelumab Import and Export
5.4 Europe Avelumab Market Analysis
5.4.1 Europe Avelumab Production
5.4.2 Europe Avelumab Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Avelumab Import and Export
5.5 China Avelumab Market Analysis
5.5.1 China Avelumab Production
5.5.2 China Avelumab Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Avelumab Import and Export
5.6 Japan Avelumab Market Analysis
5.6.1 Japan Avelumab Production
5.6.2 Japan Avelumab Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Avelumab Import and Export
5.7 Southeast Asia Avelumab Market Analysis
5.7.1 Southeast Asia Avelumab Production
5.7.2 Southeast Asia Avelumab Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Avelumab Import and Export
5.8 India Avelumab Market Analysis
5.8.1 India Avelumab Production
5.8.2 India Avelumab Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Avelumab Import and Export
6 Avelumab Segment Market Analysis (by Type)
6.1 Global Avelumab Production by Type
6.2 Global Avelumab Revenue by Type
6.3 Avelumab Price by Type
7 Avelumab Segment Market Analysis (by Application)
7.1 Global Avelumab Consumption by Application
7.2 Global Avelumab Consumption Market Share by Application (2014-2019)
8 Avelumab Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Avelumab Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Avelumab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Avelumab Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Avelumab Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
9 Development Trend of Analysis of Avelumab Market
9.1 Global Avelumab Market Trend Analysis
9.1.1 Global Avelumab Market Size (Volume and Value) Forecast 2019-2025
9.2 Avelumab Regional Market Trend
9.2.1 North America Avelumab Forecast 2019-2025
9.2.2 Europe Avelumab Forecast 2019-2025
9.2.3 China Avelumab Forecast 2019-2025
9.2.4 Japan Avelumab Forecast 2019-2025
9.2.5 Southeast Asia Avelumab Forecast 2019-2025
9.2.6 India Avelumab Forecast 2019-2025
9.3 Avelumab Market Trend (Product Type)
9.4 Avelumab Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Avelumab Distributors List
10.3 Avelumab Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Avelumab
Table Global Avelumab Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Avelumab Production Market Share by Types in 2018
Figure Injection Product Picture
Figure Product Picture
Table Global Avelumab Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Avelumab Consumption Market Share by Applications in 2018
Figure Merkel-cell Carcinoma
Figure Non-small Cell Lung Carcinoma (NSCLC)
Figure Other
Figure Global Avelumab Revenue (Million USD) (2014-2025)
Figure Global Avelumab Production (K Pcs) (2014-2025)
Figure North America Avelumab Market Size (Million USD) (2014-2025)
Figure Europe Avelumab Market Size (Million USD) (2014-2025)
Figure China Avelumab Market Size (Million USD) (2014-2025)
Figure Japan Avelumab Market Size (Million USD) (2014-2025)
Figure Southeast Asia Avelumab Market Size (Million USD) (2014-2025)
Figure India Avelumab Market Size (Million USD) (2014-2025)
Table Avelumab Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Avelumab in 2018
Figure Manufacturing Process Analysis of Avelumab
Figure Industry Chain Structure of Avelumab
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Avelumab Manufacturing Plants Distribution
Table Avelumab Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Avelumab Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Avelumab Production (K Pcs) of Major Manufacturers (2014-2019)
Table Avelumab Production Market Share of Major Manufacturers (2014-2019)
Figure Avelumab Production Share by Manufacturers in 2018
Table Avelumab Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Avelumab Revenue Market Share of Major Manufacturers (2014-2019)
Figure Avelumab Revenue Share by Manufacturers in 2018
Table Avelumab Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Avelumab Production by Regions 2014-2019 (K Pcs)
Table Global Avelumab Production Market Share by Regions 2014-2019
Figure Global Avelumab Production Market Share by Regions in 2018
Table Global Avelumab Revenue by Regions 2014-2019 (Million USD)
Table Global Avelumab Revenue Market Share by Regions 2014-2019
Figure Global Avelumab Revenue Market Share by Regions in 2018
Table Global Avelumab Consumption by Regions 2014-2019 (K Pcs)
Table Global Avelumab Consumption Market Share by Regions 2014-2019
Figure North America Avelumab Production Growth Rate 2014-2019 (K Pcs)
Figure North America Avelumab Revenue Growth Rate 2014-2019 (Million USD)
Table North America Avelumab Production, Consumption Import and Export (K Pcs)
Figure Europe Avelumab Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Avelumab Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Avelumab Production, Consumption Import and Export (K Pcs)
Figure China Avelumab Production Growth Rate 2014-2019 (K Pcs)
Figure China Avelumab Revenue Growth Rate 2014-2019 (Million USD)
Table China Avelumab Production, Consumption Import and Export (K Pcs)
Figure Japan Avelumab Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Avelumab Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Avelumab Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Avelumab Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Avelumab Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Avelumab Production, Consumption Import and Export (K Pcs)
Figure India Avelumab Production Growth Rate 2014-2019 (K Pcs)
Figure India Avelumab Revenue Growth Rate 2014-2019 (Million USD)
Table India Avelumab Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Avelumab Market Share by Application (2014-2019)
Figure Global Value (Consumption) Avelumab Market Share by Application (2014-2019)
Table Merck Avelumab Production Sites and Area Served
Table Merck Avelumab Product Introduction, Application and Specification
Table Merck Avelumab Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck Avelumab Production Growth Rate (2014-2019)
Table Merck Avelumab Production Market Share (2014-2019)
Figure Merck Avelumab Revenue Market Share (2014-2019)
Table Merck Avelumab Main Business and Markets Served
Table Pfizer Avelumab Production Sites and Area Served
Table Pfizer Avelumab Product Introduction, Application and Specification
Table Pfizer Avelumab Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Avelumab Production Growth Rate (2014-2019)
Table Pfizer Avelumab Production Market Share (2014-2019)
Figure Pfizer Avelumab Revenue Market Share (2014-2019)
Table Pfizer Avelumab Main Business and Markets Served
Figure Global Avelumab Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Avelumab Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Avelumab Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Avelumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Avelumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Avelumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Avelumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Avelumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Avelumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Avelumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Avelumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Avelumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Avelumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Avelumab Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Avelumab Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Avelumab by Type (2019-2025)
Table Global Consumption (K Pcs) of Avelumab by Application (2019-2025)
Table Avelumab Distributors List
Table Avelumab Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のアベルマブ市場：専門的調査 The global Avelumab market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Avelumab volume and value at global level, regional level and company level. From a global perspective, this report repr…- 基底細胞癌治療の世界市場：市場規模・現状・予測 Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…
- 進行腎細胞癌治療薬の世界市場：市場規模・現状・予測 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …
- 非小細胞肺癌治療薬の世界市場：市場規模・現状・予測 Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness of breath. Due an increase in the incidence of lung cancer, the global lung cancer therapeutics market is expected to expand at a r…
- 小細胞肺がん治療薬の世界市場：市場規模・現状・予測 Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…